PPR Affiliates in the News – Penn Program on Regulation

PPR Affiliates in the News

FDA Seems Poised to Approve a New Drug for ALS, but Does it Work?

September 21, 2022• PPR Affiliates in the News

...

Read More →

Here’s How to Make it Easier for Workers to Find Better Jobs

September 14, 2022• PPR Affiliates in the News

...

Read More →

David Zaring

Trump Judges are on a Tear

September 12, 2022• PPR Affiliates in the News

Read More →

Federal Judge Rules HIV Prevention Drugs Coverage in Affordable Care Act Violates Christians’ Religious Freedom

September 9, 2022• PPR Affiliates in the News

Allison Hoffman in Christianity Daily, Sep 9, 2022...

Read More →

The Debate over a New ALS Drug Harkens Back to the Aduhelm Controversy

September 8, 2022• PPR Affiliates in the News

Holly Fernandez Lynch in Washington Post, Sep 8, 2022...

Read More →

When Big Was Not Bad: Lessons from Congress’s Decisions Not to Enact Antitrust Reform

September 7, 2022• PPR Affiliates in the News

Read More →

Jill E. Fisch

Corning, Polaris Pressed on Climate Reporting as SEC Wraps Rules

September 7, 2022• PPR Affiliates in the News

Jill Fisch in Bloomberg Law, Sep 7, 2022...

Read More →

FDA Still Skeptical of ALS Drug Ahead of High-Stakes Meeting

September 2, 2022• PPR Affiliates in the News

Holly Fernandez Lynch in WRAL, Sep 2, 2022...

Read More →

Bail Reform Leads to Drop in Jail Time, Recidivism: Study

August 31, 2022• PPR Affiliates in the News

Read More →